User login

RESSTORE is a challenging European project to develop reparative medicine for stroke patients. Improving patients’ recovery requires experts of cell therapy products, neurosciences, and stroke neurology. Innovative multimodal MRI and statistics also increase our knowledge about stroke pathophysiology and treatment effects.
While we have just obtained the regulatory and ethics approval, we will start the clinical trial in the next weeks. It is our pleasure to present here the first RESSTORE newsletter on behalf of the European consortium including France, Spain, Finland, Czech Republic and UK.

[[{"fid":"229","view_mode":"default","fields":{"format":"default","field_file_image_alt_text[und][0][value]":false,"field_file_image_title_text[und][0][value]":false},"type":"media","field_deltas":{"4":{"format":"default","field_file_image_alt_text[und][0][value]":false,"field_file_image_title_text[und][0][value]":false}},"attributes":{"class":"media-element file-default","data-delta":"4"}}]]

[[{"fid":"227","view_mode":"default","fields":{"format":"default"},"type":"media","field_deltas":{"2":{"format":"default"}},"link_text":"RESSTORE_1st_newsletter_June_2018.pdf","attributes":{"class":"media-element file-default","data-delta":"2"}}]]